Insider Transactions in Q2 2025 at Inozyme Pharma, Inc. (INZY)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2025
|
Sanjay Subramanian SVP, CFO & Head of BD |
BUY
Grant, award, or other acquisition
|
Direct |
6,813
+14.65%
|
$0
$0.74 P/Share
|
|
Jun 25
2025
|
Douglas A Treco CEO & Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
2,815
+6.03%
|
$0
$0.74 P/Share
|
|
Jun 25
2025
|
Matthew Winton COO |
BUY
Grant, award, or other acquisition
|
Direct |
14,355
+39.77%
|
$0
$0.74 P/Share
|
|
May 15
2025
|
Axel Bolte |
BUY
Exercise of conversion of derivative security
|
Direct |
157,230
+13.87%
|
$0
$0.98 P/Share
|
|
Apr 02
2025
|
Douglas A Treco CEO & Chairman |
SELL
Open market or private sale
|
Direct |
8,819
-17.69%
|
$0
$0.89 P/Share
|
|
Apr 01
2025
|
Douglas A Treco CEO & Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+33.39%
|
-
|